Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts. Show More...
-
Website https://www.enanta.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 5.93 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-09 2011-09 2012-09 2013-09 2014-09 2015-09 2016-09 2017-09 2018-09 2019-09 TTM Earnings Per Share USD 0.02 0.59 0.52 -0.67 1.8 4.09 1.13 0.91 3.48 2.21 1.13 Dividends USD Payout Ratio % * Shares Mil 14.0 3.0 3.0 10.0 19.0 19.0 19.0 19.0 21.0 21.0 21.0 Book Value Per Share * USD 6.38 8.23 12.2 14.13 13.64 18.61 22.74 24.29 Free Cash Flow Per Share * USD 0.61 1.16 3.78 1.54 -0.5 2.71 4.07 Return on Assets % 6.0 54.72 -7.77 25.29 39.36 8.22 5.83 19.42 10.26 4.85 Financial Leverage (Average) 1.06 1.05 1.04 1.04 1.08 1.05 1.06 1.06 Return on Equity % 26.58 41.06 8.56 6.2 20.7 10.84 5.13 Return on Invested Capital % 26.36 40.61 8.1 5.61 20.68 10.83 5.06 Interest Coverage 8.37 311.55 724.56 674.67 Current Ratio 11.68 8.25 23.14 22.75 25.45 29.43 11.33 23.74 17.77 20.63 Quick Ratio 10.98 8.15 22.77 20.07 24.0 28.26 11.17 23.46 17.1 19.62 Debt/Equity 0.010